[1] |
Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis[J]. J Am Acad Dermatol, 2012,67(4):495.e1⁃17; quiz 512⁃514. doi: 10.1016/j.jaad.2012.06.023.
|
[2] |
Lin WM, Luo S, Muzikansky A, et al. Outcome of patients with de novo versus nevus⁃associated melanoma[J]. J Am Acad Dermatol, 2015,72(1):54⁃58. doi: 10.1016/j.jaad.2014.09.028.
|
[3] |
Pampena R, Kyrgidis A, Lallas A, et al. A meta⁃analysis of nevus⁃associated melanoma: prevalence and practical implications[J]. J Am Acad Dermatol, 2017,77(5):938⁃945.e4. doi: 10.1016/j.jaad.2017.06.149.
|
[4] |
高天文, 刘玉峰, 刘荣卿, 等. 对色素痣恶变几个问题的探讨[J]. 中国皮肤性病学杂志, 1996,10(1):3⁃4,62.
|
[5] |
Rhodes AR. The risk of malignant melanoma arising in congenital melanocytic nevi. An argument against the assignment of risk based on size alone[J]. Am J Dermatopathol, 1984,6 Suppl:184⁃188.
|
[6] |
Friedman RJ, Rigel DS, Kopf AW, et al. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi[J]. Arch Dermatol, 1983,119(6):455⁃462.
|
[7] |
Herron MD, Vanderhooft SL, Smock K, et al. Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis[J]. Am J Surg Pathol, 2004,28(8):1017⁃1025. doi: 10.1097/01.pas.0000126785.61609.6e.
|
[8] |
Belysheva TS, Vishnevskaya YV, Nasedkina TV, et al. Melanoma arising in a giant congenital melanocytic nevus: two case reports[J]. Diagn Pathol, 2019,14(1):21. doi: 10.1186/s13000⁃019⁃0797⁃1.
|
[9] |
高天文, 王雷, 廖文俊, 等. 实用皮肤组织病理学[M]. 2版. 北京: 人民卫生出版社, 2017:652⁃655.
|
[10] |
Duman N, Erkin G, Gököz Ö, et al. Nevus⁃associated versus de novo melanoma: do they have different characteristics and prognoses?[J]. Dermatopathology (Basel), 2015,2(1):46⁃51. doi: 10.1159/000375490.
|
[11] |
Lian CG, Xu Y, Ceol C, et al. Loss of 5⁃hydroxymethylcytosine is an epigenetic hallmark of melanoma[J]. Cell, 2012,150(6):1135⁃1146. doi: 10.1016/j.cell.2012.07.033.
|
[12] |
Busam KJ, Shah KN, Gerami P, et al. Reduced H3K27me3 expression is common in nodular melanomas of childhood associated with congenital melanocytic nevi but not in proliferative nodules[J]. Am J Surg Pathol, 2017,41(3):396⁃404. doi: 10.1097/PAS.0000000000000769.
|
[13] |
Pavlova O, Fraitag S, Hohl D. 5⁃Hydroxymethylcytosine expression in proliferative nodules arising within congenital nevi allows differentiation from malignant melanoma[J]. J Invest Dermatol, 2016,136(12):2453⁃2461. doi: 10.1016/j.jid.2016.07. 015.
|
[14] |
Kiyohara T, Takata M, Itoh H, et al. Malignant melanoma arising from an NRAS⁃mutated medium⁃sized congenital melanocytic nevus[J]. J Dermatol, 2012,39(12):1034⁃1035. doi: 10.1111/j.1346⁃8138.2012.01542.x.
|
[15] |
Shain AH, Yeh I, Kovalyshyn I, et al. The genetic evolution of melanoma from precursor lesions[J]. N Engl J Med, 2015,373(20):1926⁃1936. doi: 10.1056/NEJMoa1502583.
|
[16] |
Shitara D, Tell⁃Martí G, Badenas C, et al. Mutational status of naevus⁃associated melanomas[J]. Br J Dermatol, 2015,173(3):671⁃680. doi: 10.1111/bjd.13829.
|
[17] |
Roh MR, Eliades P, Gupta S, et al. Genetics of melanocytic nevi[J]. Pigment Cell Melanoma Res, 2015,28(6):661⁃672. doi: 10. 1111/pcmr.12412.
|
[18] |
Salgado CM, Basu D, Nikiforova M, et al. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis[J]. Melanoma Res, 2015,25(5):453⁃460. doi: 10. 1097/CMR.0000000000000188.
|
[19] |
Lalor L, Busam K, Shah K. Prepubertal melanoma arising within a medium⁃sized congenital melanocytic nevus[J]. Pediatr Dermatol, 2016,33(6):e372⁃e374. doi: 10.1111/pde. 12961.
|
[20] |
Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin[J]. Pigment Cell Melanoma Res, 2011,24(5):879⁃897. doi: 10.1111/j.1755⁃148X.2011.00880.x.
|
[21] |
Cymerman RM, Shao Y, Wang K, et al. De novo vs nevus⁃associated melanomas: differences in associations with prognostic indicators and survival[J]. J Natl Cancer Inst, 2016,108(10):djw121. doi: 10.1093/jnci/djw121.
|
[22] |
陈凤鸣, 亢寒梅, 高天文, 等. 先天性色素痣伴增生性结节10例临床病理分析[J]. 中华皮肤科杂志, 2021,54(9):785⁃789. doi: 10.35541/cjd.20200945.
|
[23] |
Bastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas[J]. Am J Pathol, 2002,161(4):1163⁃1169. doi: 10.1016/S0002⁃9440(10)64393⁃3.
|
[24] |
刘芳, 李璨宇, 方卉, 等. 婴幼儿先天性色素痣126例临床及病理特征分析[J]. 中华皮肤科杂志, 2021,54(1):42⁃49. doi: 10.35541/cjd.20200754.
|
[25] |
耿怡, 宋昊, 徐秀莲, 等. 先天性色素痣恶变三例[J]. 中华皮肤科杂志, 2018,51(11):832⁃833. doi: 10.3760/cma.j.issn.0412⁃4030.2018.11.021.
|